Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Japanese NHI price listing for Nicotinell TTS

June 2, 2006

Proof-of-concept study for NicVAX in smoking cessation

May 29, 2006

Recent Merz patent discloses novel agents for drug addiction

May 24, 2006

SRI awarded NIAID contract to produce oral formulations for antiradiation drugs

May 23, 2006

FDA approval for smoking cessation therapy Chantix

May 12, 2006

Celtic cleared in U.K. to begin phase II study of TA-NIC

May 9, 2006

BioTie grants Britannia nalmefene marketing rights for U.K. and Ireland

May 4, 2006

Vivitrol approved for treatment of alcohol dependence

April 18, 2006

Galantamine and smoking cessation / News in Context

April 3, 2006

NicVAX awarded fast track designation

March 13, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...